BriaCell Therapeutics Corp.; BriaPro Therapeutics Corp.

Contributing Author

Recent Articles by BriaCell Therapeutics Corp.; BriaPro Therapeutics Corp.

Mar-31	BriaCell and BriaPro Announce Closing of Asset Purchase Transaction for Exclusive Soluble CD80 License BCTX GlobeNewswire
Feb-18	BriaCell and BriaPro Enter Into Asset Purchase Agreement for Exclusive Soluble CD80 License BCTX GlobeNewswire
Jul-29	BriaCell's Subsidiary, BriaPro, Files Patent Application for Immuno-Oncology Platform with Novel Multitargeting Agents BCTX GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information